B

bremelanotide

Product

by AMAG Pharmaceuticals

Heard in 4 episodes across 3 shows since Aug 2026

A melanocortin receptor agonist marketed as Vyleesi and approved in the United States for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.

Learn more
Discussed inHealth & Science100%

Episodes

4
across 3 shows

This week

0
episodes on 0 shows

Share of the conversation

Mentions of bremelanotide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰0.08‰Jul 11Aug 2Aug 25Sep 16Oct 8
Show the data
DayShare (7-day)Mentions
Aug 80.07‰1
Aug 250.07‰2
Sep 10.03‰1
Sep 90.04‰1

The full trend: rank, tone and why it is trending →

Episodes

4 episodes featuring bremelanotide, newest first

bremelanotide · PodLume